You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RXDX-101

Showing 1 - 25 of 681
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine and Cedazuridine
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 25, 2022

Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

Recruiting
  • Solid Tumors
  • CNS Tumors
  • Orange, California
  • +38 more
Aug 24, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Korea, Republic of, United States (Entrectinib)

Completed
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Orange, California
  • +9 more
Jun 7, 2021

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Cancers With NTRK, ROS1, or ALK Gene Fusions Trial in San Diego (Entrectinib)

No longer available
  • Cancers With NTRK, ROS1, or ALK Gene Fusions
  • San Diego, California
    1-844-Startrk (782-7875)
Apr 24, 2019

ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

Terminated
Has Results
  • ALK Fusion Protein Expression
  • +14 more
  • San Francisco, California
    University of California, San Francisco
Jan 14, 2020

Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

Not yet recruiting
  • Chronic Hepatitis b
  • Auckland, New Zealand
    New Zealand Clinical Research Auckland
Jul 26, 2023

Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • KSD-101
  • Wuhan, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 19, 2023

Solid Tumor Trial in China (BPB-101)

Not yet recruiting
  • Solid Tumor
  • Guangzhou, Guangdong, China
  • +3 more
May 11, 2023

Frontotemporal Dementia, FTD, FTD-GRN Trial in Poland, Spain (Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101)

Recruiting
  • Frontotemporal Dementia
  • +3 more
  • Intrathalamic AAV.PGRN administration
  • Intrathalamic AVB-101
  • Katowice, Poland
  • +3 more
Oct 6, 2023

Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -

Completed
  • Nonalcoholic Fatty Liver Disease
  • Anti-human CCL24 monoclonal antibody (CM-101) - Part One
  • +3 more
  • Jerusalem, Israel
    Hadassah University Hospital - Ein Kerem
Sep 13, 2023

Community-acquired Pneumonia, Bacterial Pneumonia Trial in Cincinnati (CMTX-101, Placebo)

Recruiting
  • Community-acquired Pneumonia
  • Bacterial Pneumonia
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology Unit
Jan 20, 2023

Cancer Trial (Antibody-Drug Conjugate)

Not yet recruiting
  • Cancer
  • Antibody-Drug Conjugate
  • (no location specified)
Aug 23, 2023

Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical

Not yet recruiting
  • Epidermolysis Bullosa
  • +2 more
  • EB-101 Surgical application of RDEB wounds
  • Redwood City, California
  • +1 more
Feb 13, 2023

NSCLC, HNSCC, Melanoma Trial (CJRB-101, Pembrolizumab injection)

Not yet recruiting
  • NSCLC
  • +5 more
  • (no location specified)
Jun 1, 2023

Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,

Not yet recruiting
  • Idiopathic Inflammatory Myopathies
  • +3 more
  • (no location specified)
Nov 21, 2023

Orthostatic Hypotension Trial in Newcastle Upon Tyne (ISO-101)

Not yet recruiting
  • Orthostatic Hypotension
  • ISO-101
  • Newcastle Upon Tyne, United Kingdom
    Falls and Syncope Service, Older People's Medicine, The Newcastl
Sep 8, 2023

Oropharyngeal Squamous Cell Carcinoma Trial in Saint Louis (CUE-101)

Recruiting
  • Oropharyngeal Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

Pulmonary Arterial Hypertension Trial in Indianapolis (AV-101)

Recruiting
  • Pulmonary Arterial Hypertension
  • Indianapolis, Indiana
    Indiana University Health
Dec 6, 2022

HIV-1-infection Trial in San Francisco, Saint Louis, Camden (EBT-101)

Enrolling by invitation
  • HIV-1-infection
  • EBT-101
  • San Francisco, California
  • +2 more
Oct 17, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 6, 2023

Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)

Recruiting
  • Age-Related Macular Degeneration
  • VOY-101
  • Sydney, New South Wales, Australia
  • +3 more
Oct 17, 2023

Alpha 1-Antitrypsin Deficiency, Emphysema Trial (INBRX-101)

Not yet recruiting
  • Alpha 1-Antitrypsin Deficiency
  • Emphysema
  • (no location specified)
May 31, 2023

Glucocorticoids Toxicity, COVID-19, Infectious Disease Trial in Bangalore (101-PGC-005)

Active, not recruiting
  • Glucocorticoids Toxicity
  • +3 more
  • Bangalore, Karnataka, India
    ICBio Clinical Research Pvt. Ltd.
Dec 13, 2022